Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study

<b>Background:</b> With advances in antiretroviral therapy for HIV treatment, newer drug combinations provide improved efficacy, safety, and compliance. This study evaluates switching to a regimen of doravirine (DOR), tenofovir disoproxil fumarate (TDF), and lamivudine (3TC) in a cohort of people li...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Stefania Cicalini, Simone Lanini, Roberta Gagliardini, Rita Bellagamba, Alessandra Vergori, Ilaria Mastrorosa, Valentina Mazzotta, Rozenn Esvan, Maria Maddalena Plazzi, Sandrine Ottou, Elisabetta Grilli, Federico De Zottis, Marisa Fusto, Jessica Paulicelli, Andrea Antinori
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	MDPI AG 2024-12-01
Serie:	Pharmaceuticals
Ämnen:	non-nucleoside reverse transcriptase inhibitors (NNRTIs) antiretroviral therapy optimization single tablet regimen (STR)
Länkar:	https://www.mdpi.com/1424-8247/17/12/1706
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!